Company profile
StemBond Technologies: Harnessing Cell Culture for Regenerative Medicine
Stembond Technologies Ltd is a UK company with status active founded in 2021 based in East of England.
Financial period: 1 Sep 2024 to 31 Aug 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzMjk0MjE5MmFkaXF6a2N4
Published 21 Aug 2024 13:02
TM01 | Transaction MzQzMjk0MTYzNmFkaXF6a2N4
Published 21 Aug 2024 12:57
CH01 | Transaction MzQzMjc2OTkyOWFkaXF6a2N4
Published 20 Aug 2024 15:18
Company registered at Companies House
1 Nov 2024 to 31 Mar 2026
StemBond Technologies is harnessing the power of advanced materials science to ignite a cell therapy revolution. We specialise in preserving the vitality and functionality of cells cultured outside the body, addressing pivotal challenges in the manufacturing of cell and gene therapies. Our mission is to empower the development of cell therapies, enhance t...
1 Jun 2023 to 30 Nov 2023
Why are cells not regularly used as medicine? If our cells repair us, keep us safe from pathogens and form our immune system, why do we not grow more in laboratories to help our bodies when needed? This is the basis of cell-based medicine: using cells to produce therapeutic products or to be transplanted into patients as therapy. One of the main applicati...
